MicroRNAs and chinese medicinal herbs: New possibilities in cancer therapy

Cancers

Volumn 7, Issue 3, 2015, Pages 1643-1657

  Hong, Ming ^a   Wang, Ning ^a   Tan, Hor Yue ^a   Tsao, Sai Wah ^b   Feng, Yibin ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer therapy; Chinese medicinal herbs; Exogenous microRNAs; MicroRNAs

Indexed keywords

10 HYDROXYCAMPTOTHECIN; AIDI; BERBERINE; CAMPTOTHECIN; CHINESE DRUG; COPTIS RHIZOME EXTRACT; CURCUMIN; EPIGALLOCATECHIN GALLATE; GANODERMA SPORE LIPID; GENISTEIN; GINSENOSIDE RH 2; HERBACEOUS AGENT; HONOKIOL; ISOFLAVONE DERIVATIVE; LUTEOLIN; MATRINE; MICRORNA; MICRORNA 106; MICRORNA 168; MICRORNA 17; MICRORNA 18A; MICRORNA 21; MICRORNA 328; MICRORNA 33B; MICRORNA 34A; MICRORNA 99A; PANAX NOTOGINSENG EXTRACT; RESVERATROL; UNCLASSIFIED DRUG; VISCUM ALBUM LECTIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER STEM CELL; CANCER SURVIVAL; CANCER THERAPY; CELL CYCLE ARREST; CHINESE MEDICINE; DOWN REGULATION; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; METASTASIS INHIBITION; NONHUMAN; PDCD4 GENE; PROTEIN EXPRESSION; PTEN GENE; REVIEW; SYSTEMATIC REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84940975280     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers7030855     Document Type: Review

References (73)

1. Kataoka, M.; Wang, D.Z. Non-coding RNAs including miRNAs and lncRNAs in cardiovascular biology and disease. Cells 2014, 3, 883-898. [CrossRef] [PubMed]
2. Irminger-Finger, I.; Kargul, J.; Laurent, G.J. Non-coding RNAs: A novel level of genome complexity. Int. J. Biochem. Cell Biol. 2014, 54, 286. [CrossRef] [PubMed]
3. Hajjari, M.; Khoshnevisan, A.; Shin, Y.K. Molecular function and regulation of long non-coding RNAs: Paradigms with potential roles in cancer. Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. 2014, 35, 10645-10663. [CrossRef] [PubMed]
4. Tian, T.; Wang, J.; Zhou, X. A review: MicroRNA detection methods. Org. Biomol. Chem. 2015, 13, 2226-2238. [CrossRef] [PubMed]
5. Zhou, X.L.; Wu, J.H.; Wang, X.J.; Guo, F.J. Integrated microRNA-mRNA analysis revealing the potential roles of microRNAs in tongue squamous cell cancer. Mol. Med. Rep. 2015, 12, 885-894. [CrossRef] [PubMed]
6. Shrestha, S.; Hsu, S.D.; Huang, W.Y.; Huang, H.Y.; Chen, W.; Weng, S.L.; Huang, H.D. A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med. 2014, 3, 878-888. [CrossRef] [PubMed]
7. Li, X.; Abdel-Mageed, A.B.; Mondal, D.; Kandil, E. MicroRNA expression profiles in differentiated thyroid cancer, a review. Int. J. Clin. Exp. Med. 2013, 6, 74-80. [PubMed]
8. Pocock, R. Invited review: Decoding the microRNA response to hypoxia. Pflugers Arch. Eur. J. Physiol. 2011, 461, 307-315. [CrossRef] [PubMed]
9. Li, M.; Li, J.; Liu, L.; Li, W.; Yang, Y.; Yuan, J. MicroRNA in human glioma. Cancers 2013, 5, 1306-1331. [CrossRef] [PubMed]
10. Das, J.; Podder, S.; Ghosh, T.C. Insights into the miRNA regulations in human disease genes. BMC Genom. 2014, 15, 1010. [CrossRef] [PubMed]
11. Shapshak, P. Molecule of the month: MiRNA and human prion brain disease. Bioinformation 2013, 9, 659-660. [CrossRef] [PubMed]
12. Lukiw, W.J. Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to alzheimer's disease (AD). Front. Cell. Neurosci. 2013, 7, 133. [CrossRef] [PubMed]
13. Volinia, S.; Galasso, M.; Costinean, S.; Tagliavini, L.; Gamberoni, G.; Drusco, A.; Marchesini, J.; Mascellani, N.; Sana, M.E.; Abu Jarour, R.; et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010, 20, 589-599. [CrossRef] [PubMed]
14. Mackenzie, N.C.; Staines, K.A.; Zhu, D.; Genever, P.; Macrae, V.E. miRNA-221 and miRNA-222 synergistically function to promote vascular calcification. Cell Biochem. Funct. 2014, 32, 209-216. [CrossRef] [PubMed]
15. Zhu, D.X.; Miao, K.R.; Zhu, Y.D.; Zhu, H.Y.; Fan, L.; Liu, P.; Xu, W.; Li, J.Y. Detection of miRNA levels in leukemia patients by real-time quantitative PCR. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010, 18, 757-761. [PubMed]
16. Plaisier, C.L.; Pan, M.; Baliga, N.S. A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers. Genome Res. 2012, 22, 2302-2314. [CrossRef] [PubMed]
17. Kjersem, J.B.; Ikdahl, T.; Guren, T.; Skovlund, E.; Sorbye, H.; Hamfjord, J.; Pfeiffer, P.; Glimelius, B.; Kersten, C.; Solvang, H.; et al. Let-7 miRNA-binding site polymorphism in the KRAS 3ʹUTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab. BMC Cancer 2012, 12, 534. [CrossRef] [PubMed]
18. Lionetti, M.; Musto, P.; Di Martino, M.T.; Fabris, S.; Agnelli, L.; Todoerti, K.; Tuana, G.; Mosca, L.; Gallo Cantafio, M.E.; Grieco, V.; et al. Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia. Clin. Cancer Res. 2013, 19, 3130-3142. [CrossRef] [PubMed]
19. Akbari Moqadam, F.; Lange-Turenhout, E.A.; Aries, I.M.; Pieters, R.; den Boer, M.L. MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia. Leuk. Res. 2013, 37, 1315-1321. [CrossRef] [PubMed]
20. Liu, M.X.; Siu, M.K.; Liu, S.S.; Yam, J.W.; Ngan, H.Y.; Chan, D.W. Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer. Oncotarget 2014, 5, 944-958. [PubMed]
21. Su, C.X.; Wang, L.Q.; Grant, S.J.; Liu, J.P. Chinese herbal medicine for cancer-related fatigue: A systematic review of randomized clinical trials. Complement. Ther. Med. 2014, 22, 567-579. [CrossRef] [PubMed]
22. Chen, C.M.; Lin, L.Z.; Zhang, E.X. Standardized treatment of chinese medicine decoction for cancer pain patients with opioid-induced constipation: A multi-center prospective randomized controlled study. Chin. J. Integr. Med. 2014, 20, 496-502. [CrossRef] [PubMed]
23. Luo, F.R.; Ding, J.; Chen, H.X.; Liu, H.; Fung, M.C.; Koehler, M.; Armand, J.P.; Jiang, L.; Xu, X.; Zhang, G.; et al. Breakthrough cancer medicine and its impact on novel drug development in China: Report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (Csco) Joint Session at the 17th CSCO Annual Meeting. Chin. J. Cancer 2014, 33, 620-624. [CrossRef] [PubMed]
24. Li, M.; Qiao, C.; Qin, L.; Zhang, J.; Ling, C. Application of traditional chinese medicine injection in treatment of primary liver cancer: A review. J. Tradit. Chin. Med. 2012, 32, 299-307. [CrossRef]
25. Yang, D.; Tian, G. Review of experimental study on treatment of lung cancer with traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi 2009, 34, 2405-2409. [PubMed]
26. Yang, C.H.; Yue, J.; Sims, M.; Pfeffer, L.M. The curcumin analog EF24 targets NF-kappaB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS ONE 2013, 8, e71130. [CrossRef] [PubMed]
27. Feng, M.; Luo, X.; Gu, C.; Li, Y.; Zhu, X.; Fei, J. Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of miR-99a approximately 125b cluster function by seed-targeting inhibitors in multiple myeloma cells. RNA Biol. 2015, 12, 82-91. [CrossRef] [PubMed]
28. Liu, S.; Fang, Y.; Shen, H.; Xu, W.; Li, H. Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis. Acta Biochim. Biophys. Sin. 2013, 45, 756-762. [CrossRef] [PubMed]
29. Zeng, C.W.; Zhang, X.J.; Lin, K.Y.; Ye, H.; Feng, S.Y.; Zhang, H.; Chen, Y.Q. Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways. Mol. Pharmacol. 2012, 81, 578-586. [CrossRef] [PubMed]
30. Ren, X.; Bai, X.; Zhang, X.; Li, Z.; Tang, L.; Zhao, X.; Li, Z.; Ren, Y.; Wei, S.; Wang, Q.; et al. Quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cells. Mol. Cell. Proteom. MCP 2015, 14, 316-328. [CrossRef] [PubMed]
31. Liu, P.; Liang, H.; Xia, Q.; Li, P.; Kong, H.; Lei, P.; Wang, S.; Tu, Z. Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression. Clin. Transl. Oncol. 2013, 15, 741-746. [CrossRef] [PubMed]
32. Wu, H.; Huang, M.; Liu, Y.; Shu, Y.; Liu, P. Luteolin induces apoptosis by up-regulating miR-34a in human gastric cancer cells. Technol. Cancer Res. Treat. 2014, 2014. [CrossRef] [PubMed]
33. Hirata, H.; Hinoda, Y.; Shahryari, V.; Deng, G.; Tanaka, Y.; Tabatabai, Z.L.; Dahiya, R. Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells. Br. J. Cancer 2014, 110, 1645-1654. [CrossRef] [PubMed]
34. Lin, Y.; Lin, L.; Jin, Y.; Zhang, Y.; Wang, D.; Tan, Y.; Zheng, C. Combination of matrine and sorafenib decreases the aggressive phenotypes of hepatocellular carcinoma cells. Chemotherapy 2015, 60, 112-118. [CrossRef] [PubMed]
35. Brabletz, T. EMT and MET in metastasis: Where are the cancer stem cells? Cancer Cell 2012, 22, 699-701. [CrossRef] [PubMed]
36. Sethi, S.; Macoska, J.; Chen, W.; Sarkar, F.H. Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. Am. J. Transl. Res. 2010, 3, 90-99. [PubMed]
37. Toden, S.; Okugawa, Y.; Jascur, T.; Wodarz, D.; Komarova, N.L.; Buhrmann, C.; Shakibaei, M.; Boland, C.R.; Goel, A. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Carcinogenesis 2015, 36, 355-367. [CrossRef] [PubMed]
38. Zhang, P.; Bai, H.; Liu, G.; Wang, H.; Chen, F.; Zhang, B.; Zeng, P.; Wu, C.; Peng, C.; Huang, C.; et al. MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2. Toxicol. Lett. 2015, 234, 151-161. [CrossRef] [PubMed]
39. Yang, S.F.; Lee, W.J.; Tan, P.; Tang, C.H.; Hsiao, M.; Hsieh, F.K.; Chien, M.H. Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas. Oncotarget 2015, 6, 2736-2753. [PubMed]
40. Li, Y.; Vandenboom, T.G., 2nd; Wang, Z.; Kong, D.; Ali, S.; Philip, P.A.; Sarkar, F.H. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 2010, 70, 1486-1495. [CrossRef] [PubMed]
41. Yang, Q.; Wang, X.; Cui, J.; Wang, P.; Xiong, M.; Jia, C.; Liu, L.; Ning, B.; Li, L.; Wang, W.; et al. Bidirectional regulation of angiogenesis and miR-18a expression by pns in the mouse model of tumor complicated by myocardial ischemia. BMC Complemen. Altern. Med. 2014, 14, 183. [CrossRef] [PubMed]
42. Chan, L.S.; Yue, P.Y.; Mak, N.K.;Wong, R.N. Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur. J. Pharm. Sci. 2009, 38, 370-377. [CrossRef] [PubMed]
43. Yu, Y.H.; Chen, H.A.; Chen, P.S.; Cheng, Y.J.; Hsu, W.H.; Chang, Y.W.; Chen, Y.H.; Jan, Y.; Hsiao, M.; Chang, T.Y.; et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 2013, 32, 431-443. [CrossRef] [PubMed]
44. Wang, N.; Zhu, M.;Wang, X.; Tan, H.Y.; Tsao, S.W.; Feng, Y. Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of miR-23a in hepatocellular carcinoma. Biochim. Biophys. Acta 2014, 1839, 849-857. [CrossRef] [PubMed]
45. Zhu, M.; Wang, N.; Tsao, S.W.; Yuen, M.F.; Feng, Y.; Wan, T.S.; Man, K.; Feng, Y. Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with coptidis rhizoma aqueous extract. Exp. Ther. Med. 2011, 2, 27-32. [PubMed]
46. Bertozzi, D.; Marinello, J.; Manzo, S.G.; Fornari, F.; Gramantieri, L.; Capranico, G. The natural inhibitor of DNA topoisomerase I, camptothecin, modulates HIF-1alpha activity by changing miR expression patterns in human cancer cells. Mol. Cancer Ther. 2014, 13, 239-248. [CrossRef] [PubMed]
47. Chen, W.; Qiu, Y. Ginsenoside Rh2 targets EGFR by up-regulation of miR-491 to enhance anti-tumor activity in hepatitis B virus-related hepatocellular carcinoma. Cell Biochem. Biophys. 2015, 72, 325-331. [CrossRef] [PubMed]
48. Wu, N.; Wu, G.C.; Hu, R.; Li, M.; Feng, H. Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128. Acta Pharmacol. Sin. 2011, 32, 345-353. [CrossRef] [PubMed]
49. Li, L.Q.; Li, X.L.; Wang, L.; Du, W.J.; Guo, R.; Liang, H.H.; Liu, X.; Liang, D.S.; Lu, Y.J.; Shan, H.L.; et al. Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 2012, 30, 631-641. [CrossRef] [PubMed]
50. Xu, H.X.; Huang, X.E.; Li, Y.; Li, C.G.; Tang, J.H. A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. Asian Pac. J. Cancer Prev. APJCP 2011, 12, 2233-2236. [PubMed]
51. Wang, T.; Nan, H.; Zhang, C.; Wang, Y.; Zhang, X.; Li, Y.; Mulati. Aidi injection combined with FOLFOX4 chemotherapy regimen in the treatment of advanced colorectal carcinoma. J. Cancer Res. Ther. 2014, 10, S52-S55.
52. Wang, D.; Chen, Y.; Ren, J.; Cai, Y.; Liu, M.; Zhan, Q. A randomized clinical study on efficacy of Aidi injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 2004, 7, 247-249. [PubMed]
53. Zhang, H.; Zhou, Q.M.; Lu, Y.Y.; Du, J.; Su, S.B. Aidi injection alters the expression profiles of microRNAs in human breast cancer cells. J. Tradit. Chin. Med. 2011, 31, 10-16. [CrossRef]
54. Sakurai, M.A.; Ozaki, Y.; Okuzaki, D.; Naito, Y.; Sasakura, T.; Okamoto, A.; Tabara, H.; Inoue, T.; Hagiyama, M.; Ito, A.; et al. Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. PLoS ONE 2014, 9, e100124. [CrossRef] [PubMed]
55. Zhao, G.; Guo, W.; Zhao, X.; Wang, Y.; Hou, Y. Glossy ganoderma spore oil promotes apoptosis of human lung adenocarcinoma SPC-A1 through downregulation of miR-21. Zhongguo Zhong Yao Za Zhi 2011, 36, 1231-1234. [PubMed]
56. Li, L.N.; Zhang, H.D.; Zhi, R.; Yuan, S.J. Down-regulation of some miRNAs by degrading their precursors contributes to anti-cancer effect of mistletoe lectin-I. Br. J. Pharmacol. 2011, 162, 349-364. [CrossRef] [PubMed]
57. Rushworth, S.A. Targeting the oncogenic role of miRNA in human cancer using naturally occurring compounds. Br. J. Pharmacol. 2011, 162, 346-348. [CrossRef] [PubMed]
58. Roy, S.; Yu, Y.; Padhye, S.B.; Sarkar, F.H.; Majumdar, A.P. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. PLoS ONE 2013, 8, e68543. [CrossRef] [PubMed]
59. Zhang, Y.; Song, W.J.; Zhang, F.Q.; Liu, W.H.; Dou, K.F. Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma. Dig. Dis. Sci. 2011, 56, 2473-2481. [CrossRef] [PubMed]
60. Shen, Y.A.; Lin, C.H.; Chi, W.H.; Wang, C.Y.; Hsieh, Y.T.; Wei, Y.H.; Chen, Y.J. Resveratrol impedes the stemness, epithelial-mesenchymal transition, and metabolic reprogramming of cancer stem cells in nasopharyngeal carcinoma through p53 activation. Evid. Based Complement. Altern. Med. eCAM 2013, 2013. [CrossRef] [PubMed]
61. Li, W.; Wang, Q.; Su, Q.; Ma, D.; An, C.; Ma, L.; Liang, H. Honokiol suppresses renal cancer cells' metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling. Mol. Cells 2014, 37, 383-388. [CrossRef] [PubMed]
62. Zhang, L.; Hou, D.; Chen, X.; Li, D.; Zhu, L.; Zhang, Y.; Li, J.; Bian, Z.; Liang, X.; Cai, X.; et al. Exogenous plant miR168a specifically targets mammalian LDLRAP1: Evidence of cross-kingdom regulation by microRNA. Cell Res. 2012, 22, 107-126. [CrossRef] [PubMed]
63. Chen, X.; Ba, Y.; Ma, L.; Cai, X.; Yin, Y.; Wang, K.; Guo, J.; Zhang, Y.; Chen, J.; Guo, X.; et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18, 997-1006. [CrossRef] [PubMed]
64. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O'Briant, K.C.; Allen, A.; et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518. [CrossRef] [PubMed]
65. Schrauder, M.G.; Strick, R.; Schulz-Wendtland, R.; Strissel, P.L.; Kahmann, L.; Loehberg, C.R.; Lux, M.P.; Jud, S.M.; Hartmann, A.; Hein, A.; et al. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS ONE 2012, 7, e29770. [CrossRef] [PubMed]
66. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J.J.; Lotvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654-659. [CrossRef] [PubMed]
67. Arroyo, J.D.; Chevillet, J.R.; Kroh, E.M.; Ruf, I.K.; Pritchard, C.C.; Gibson, D.F.; Mitchell, P.S.; Bennett, C.F.; Pogosova-Agadjanyan, E.L.; Stirewalt, D.L.; et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA 2011, 108, 5003-5008. [CrossRef] [PubMed]
68. Witwer, K.W.; McAlexander, M.A.; Queen, S.E.; Adams, R.J. Real-time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs: Limited evidence for general uptake of dietary plant xenomirs. RNA Biol. 2013, 10, 1080-1086. [CrossRef] [PubMed]
69. Tosar, J.P.; Rovira, C.; Naya, H.; Cayota, A. Mining of public sequencing databases supports a non-dietary origin for putative foreign miRNAs: Underestimated effects of contamination in NGS. RNA 2014, 20, 754-757. [CrossRef] [PubMed]
70. Dickinson, B.; Zhang, Y.; Petrick, J.S.; Heck, G.; Ivashuta, S.; Marshall, W.S. Lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat. Biotechnol. 2013, 31, 965-967. [CrossRef] [PubMed]
71. Chen, X.; Zen, K.; Zhang, C.Y. Reply to lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat. Biotechnol. 2013, 31, 967-969. [CrossRef] [PubMed]
72. Jang, J.Y.; Lee, J.K.; Jeon, Y.K.; Kim, C.W. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. BMC Cancer 2013, 13. [CrossRef] [PubMed]
73. Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120, 15-20. [CrossRef] [PubMed]